Big Pharma Split Corp.
PRM.TO
TSX
Weiss Ratings | PRM.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Good | |||
Risk Index | Fair | |||
Risk Grade | C | |||
Reward Grade | B | |||
Rating Factors | PRM.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Excellent | |||
Growth Index | Good | |||
Efficiency Index | Excellent | |||
Solvency Index | Excellent | |||
Total Return Index | Weak | |||
Volatility Index | Fair | |||
Beta / Standard Deviation | PRM.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.39 | |||
Price History | PRM.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -0.68% | |||
30-Day Total Return | -2.05% | |||
60-Day Total Return | 2.89% | |||
90-Day Total Return | 5.20% | |||
Year to Date Total Return | 1.94% | |||
1-Year Total Return | -0.53% | |||
2-Year Total Return | 9.69% | |||
3-Year Total Return | 8.39% | |||
5-Year Total Return | 37.68% | |||
52-Week High % Change | -3.32% | |||
52-Week Low % Change | 10.23% | |||
Price | PRM.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $15.05 | |||
52-Week Low Price | $13.20 | |||
52-Week Low Price (Date) | Apr 12, 2024 | |||
52-Week High Price (Date) | Sep 14, 2023 | |||
Valuation | PRM.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 12.12M | |||
Enterprise Value | 18.85M | |||
Price/Earnings (TTM) | 19.74 | |||
Earnings Per Share (TTM) | 0.74 | |||
Earnings Per Share Growth | -525.77% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 6.56 | |||
Price/Book (Q) | 1.42 | |||
Enterprise Value/Revenue (TTM) | 7.31 | |||
Price | $14.55 | |||
Enterprise Value/EBITDA (TTM) | -- | |||
Enterprise Value/EBIT | 9.20 | |||
Market Cap Category | Nano Cap | |||
Dividends and Shares | PRM.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 1.16M | |||
Dividend Yield | 9.01% | |||
Div. Per Share (Most Recent) | $0.10 | |||
Dividend Per Share (TTM) | $1.31 | |||
Payout Ratio (TTM) | 177.14% | |||
Dividend Per Share (Most Recent) | $0.10 | |||
Company Info | PRM.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 416-649-4541 | |||
Address | 610 Chartwell Road Oakville, ON L6j 4A5 | |||
Website | www.harvestportfolios.com/closed-end-funds/big-pharma-split-corp/ | |||
Country | Canada | |||
Year Founded | 2017 | |||
Profitability | PRM.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 79.53% | |||
Profit Margin | 33.17% | |||
Management Effectiveness | PRM.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 6.21% | |||
Return on Equity | 6.91% | |||
Income Statement | PRM.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | -- | |||
Total Revenue (TTM) | 2.58M | |||
Revenue Per Share | $2.22 | |||
Gross Profit (TTM) | 2.58M | |||
EBITDA (TTM) | -- | |||
EBIT (TTM) | 2.05M | |||
Net Income (TTM) | 854.80K | |||
Net Income Avl. to Common (TTM) | 477.50K | |||
Total Revenue Growth (Q YOY) | 784.09% | |||
Earnings Growth (Q YOY) | 314.54% | |||
EPS Diluted (TTM) | 0.74 | |||
EPS Diluted Growth (Q YOY) | 330.44% | |||
Balance Sheet | PRM.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 1.16M | |||
Cash Per Share (Q) | $1.00 | |||
Total Current Assets (Q) | 1.24M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 11.56M | |||
Current Ratio (Q) | 0.143 | |||
Book Value Per Share (Q) | $10.22 | |||
Total Assets (Q) | 20.20M | |||
Total Current Liabilities (Q) | 8.64M | |||
Total Debt (Q) | 7.83M | |||
Total Liabilities (Q) | 8.64M | |||
Total Common Equity (Q) | 11.56M | |||
Cash Flow | PRM.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -- | |||
Cash from Financing (TTM) | -1.35M | |||
Net Change in Cash (TTM) | 879.30K | |||
Levered Free Cash Flow (TTM) | 1.85M | |||
Cash from Operations (TTM) | 2.23M | |||